VRS
RLAY icon

Virginia Retirement Systems’s Relay Therapeutics RLAY Stock Holding History

Virginia Retirement Systems’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784K Buy
41,900
+18,700
+81% +$271K ﹤0.01% 830
2026
Q1 		$231K Buy
23,200
+10,300
+80% +$92.1K ﹤0.01% 889
2025
Q4 		$109K Buy
+12,900
New +$92.1K ﹤0.01% 939
2023
Q3 		$122K Buy
14,500
+2,300
+19% +$24.7K ﹤0.01% 913
2023
Q2 		$153K Buy
12,200
+1,300
+12% +$16.2K ﹤0.01% 940
2023
Q1 		$180K Buy
+10,900
New +$195K ﹤0.01% 965

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Virginia Retirement Systems's RLAY Position: Q2 2026 in Review

Virginia Retirement Systems increased its Relay Therapeutics (RLAY) stake by 81% in Q2 2026, buying an estimated $271K and bringing the position to 41,900 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Virginia Retirement Systems first reported a position in RLAY in Q1 2023 and has held it in 6 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Virginia Retirement Systems held 41,900 shares of Relay Therapeutics worth $784K as of Q2 2026.
  • Virginia Retirement Systems bought 18,700 Relay Therapeutics shares in Q2 2026, an estimated $271K.
  • Relay Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #830 holding.
  • Virginia Retirement Systems first reported a position in Relay Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.